Open AccessSerum KL-6, CA19-9, CA125 and CEA are Diagnostic Biomarkers for Rheumatoid Arthritis-Associated Interstitial Lung Disease in the Chinese Population
Author(s) -
Muhan Zheng,
Lou Aiju,
Haoru Zhang,
Shijie Zhu,
Min Yang,
Lai Wei
Publication year - 2021
Publication title -
rheumatology and therapy
Language(s) - English
Resource type - Journals
eISSN - 2198-6584
pISSN - 2198-6576
DOI - 10.1007/s40744-021-00288-x
Subject(s) - medicine , interstitial lung disease , carcinoembryonic antigen , rheumatoid arthritis , gastroenterology , erythrocyte sedimentation rate , ca19 9 , idiopathic pulmonary fibrosis , population , pathology , lung , cancer , pancreatic cancer , environmental health
This study aimed to evaluate the role of tumor marker carbohydrate antigen (CA) 125 (CA125), CA19-9, carcinoembryonic antigen (CEA) and Krebs von den Lungen-6 (KL-6) in the diagnosis and determination of the severity of interstitial lung disease (ILD) in rheumatoid arthritis (RA) patients.